Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
37.38
-0.10 (-0.27%)
Feb 4, 2026, 1:02 PM EST - Market open
HRMY Market Cap
HRMY has a market cap or net worth of $2.15 billion as of February 4, 2026. Its market cap has decreased by -3.33% in one year.
Market Cap
2.15B
Enterprise Value
1.64B
1-Year Change
-3.33%
Ranking
Category
Stock Price
$37.38
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $2.15B, an increase of 366.98%. That is a compound annual growth rate of 32.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 2.16B | 0.16% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maze Therapeutics | 2.31B |
| Galapagos NV | 2.27B |
| Dianthus Therapeutics | 2.27B |
| Mesoblast | 2.26B |
| Ascentage Pharma Group International | 2.18B |
| Recursion Pharmaceuticals | 2.13B |
| Sarepta Therapeutics | 2.13B |
| Olema Pharmaceuticals | 2.06B |